Can prostate-specific antigen (PSA) be elevated during a shingles (herpes zoster) infection?

PSA Elevation During Shingles

PSA can be spuriously elevated during a shingles (herpes zoster) infection, and this should be recognized to avoid unnecessary biopsies or treatment escalation in men with known or suspected prostate disease.

Clinical Evidence

There is documented case evidence of transient PSA elevation associated with shingles reactivation 1. This represents a spurious elevation rather than true prostate pathology and should be considered in the appropriate clinical context.

Mechanism and Context

While the provided evidence doesn't detail the exact mechanism, inflammatory conditions can transiently elevate PSA levels. Shingles, being a viral reactivation causing significant inflammation, can trigger this response. This is analogous to other well-recognized causes of benign PSA elevation, such as:

• Acute prostatitis (which can cause extreme elevations, even >1,000 ng/mL) 2
• Benign prostatic hyperplasia
• Urinary tract infections
• Recent prostate manipulation

Clinical Approach

If a patient presents with elevated PSA during an active shingles outbreak:

1. Document the temporal relationship between shingles onset and PSA measurement
2. Defer aggressive intervention (such as prostate biopsy) until the acute infection resolves
3. Repeat PSA testing 4-6 weeks after shingles resolution to establish a true baseline
4. Compare to prior PSA values if available to assess the magnitude of change

Key Decision Points

• If PSA was previously normal and rises during shingles: Strongly suspect spurious elevation
• If patient is on active surveillance for prostate cancer: Do not alter management based solely on PSA during acute shingles 1
• If PSA remains elevated after infection resolution: Then proceed with standard evaluation per guidelines (consider biopsy if PSA >4.0 ng/mL or significant PSA velocity changes) 3

Common Pitfalls to Avoid

• Do not perform prostate biopsy during active shingles infection - the PSA elevation may be entirely spurious
• Do not escalate prostate cancer treatment based on PSA measured during acute viral illness
• Do not assume all PSA elevations are cancer-related - always consider benign inflammatory causes in the appropriate clinical context

PSA Velocity Considerations

Standard PSA velocity thresholds (>1.0 ng/mL per year warrants biopsy consideration 3) should not be applied when one of the measurements was obtained during acute illness. Recalculate velocity after obtaining post-infection baseline.